Literature DB >> 15381721

IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

S Kamolmatyakul1, W Chen, S Yang, Y Abe, R Moroi, A M Ashique, Y-P Li.   

Abstract

Interleukin-1alpha (IL-1alpha) is a powerful activator of osteoclast cells. However, the underlying mechanism for this activation is unknown. In this study, we reveal that IL-1alpha up-regulates the expression of cathepsin K protein, a key protease in bone resorption, by five-fold. Northern blot analysis and promoter analysis show that this induction occurs at the transcriptional level, in a dose-responsive and time-dependent manner. No increase in expression occurs in the presence of either pyrrolidine dithiocarbamate (PDTC), a selective inhibitor of NF-kappaB, or Genistein, a protein tyrosine kinase inhibitor, suggesting that IL-1alpha up-regulation may be via the tyrosine kinase-NF-kappaB pathway to regulate cathepsin K expression. Antisense oligonucleotides to p65, but not the p50 subunit of NF-kappaB, suppress the IL-1alpha-induced expression of cathepsin K. We therefore conclude that IL-1alpha up-regulates cathepsin K gene expression at the transcription level, and this regulation may be via the tyrosine-kinase-NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381721      PMCID: PMC3966556          DOI: 10.1177/154405910408301011

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  23 in total

1.  Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.

Authors:  Osami Kudo; Yosuke Fujikawa; Ichiro Itonaga; Afsie Sabokbar; Takehiko Torisu; Nicholas A Athanasou
Journal:  J Pathol       Date:  2002-10       Impact factor: 7.996

2.  IL-1alpha stimulation of osteoclast survival through the PI 3-kinase/Akt and ERK pathways.

Authors:  Zang Hee Lee; Shee Eun Lee; Chang-Woo Kim; Sang Ho Lee; Si Wouk Kim; KyuBum Kwack; Kenneth Walsh; Hong-Hee Kim
Journal:  J Biochem       Date:  2002-01       Impact factor: 3.387

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation.

Authors:  S Kamolmatyakul; W Chen; Y P Li
Journal:  J Dent Res       Date:  2001-01       Impact factor: 6.116

5.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

Review 6.  Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.

Authors:  E Romas; M T Gillespie; T J Martin
Journal:  Bone       Date:  2002-02       Impact factor: 4.398

7.  Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy.

Authors:  Yue-Xin Shan; Tung-Lin Yang; Ruben Mestril; Ping H Wang
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

8.  Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.

Authors:  Lianping Xing; Louise Carlson; Beryl Story; Zhenxing Tai; Peter Keng; Ulrich Siebenlist; Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2003-02       Impact factor: 6.741

9.  Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts.

Authors:  T Miyazaki; H Katagiri; Y Kanegae; H Takayanagi; Y Sawada; A Yamamoto; M P Pando; T Asano; I M Verma; H Oda; K Nakamura; S Tanaka
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

10.  The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.

Authors:  M L Schmitz; P A Baeuerle
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  13 in total

1.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

2.  Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.

Authors:  Takashi Miyake; Motokuni Aoki; Mariana K Osako; Munehisa Shimamura; Hironori Nakagami; Ryuichi Morishita
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

3.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 4.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

5.  Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis.

Authors:  Wei-Ping Chen; Jia-Peng Bao; Jin-Li Tang; Peng-Fei Hu; Li-Dong Wu
Journal:  Rheumatol Int       Date:  2011-10       Impact factor: 2.631

6.  RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease.

Authors:  Junqing Ma; Wei Chen; Lijie Zhang; Byron Tucker; Guochun Zhu; Hajime Sasaki; Liang Hao; Lin Wang; Hongliang Ci; Hongbing Jiang; Philip Stashenko; Yi-Ping Li
Journal:  Infect Immun       Date:  2013-04       Impact factor: 3.441

7.  Inhibiting periapical lesions through AAV-RNAi silencing of cathepsin K.

Authors:  B Gao; W Chen; L Hao; G Zhu; S Feng; H Ci; X Zhou; P Stashenko; Y P Li
Journal:  J Dent Res       Date:  2012-11-19       Impact factor: 6.116

Review 8.  Endothelial cells and cathepsins: Biochemical and biomechanical regulation.

Authors:  Manu O Platt; W Andrew Shockey
Journal:  Biochimie       Date:  2015-10-13       Impact factor: 4.079

9.  Determination of the differentiation capacities of murines' primary mononucleated cells and MC3T3-E1 cells.

Authors:  Muhammad Dain Yazid; Shahrul Hisham Zainal Ariffin; Sahidan Senafi; Mohamad Abdul Razak; Rohaya Megat Abdul Wahab
Journal:  Cancer Cell Int       Date:  2010-10-28       Impact factor: 5.722

10.  Overexpression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis.

Authors:  Sirkka Kyostio-Moore; Susan Piraino; Patricia Berthelette; Nance Moran; Joseph Serriello; Alison Bendele; Cathleen Sookdeo; Bindu Nambiar; Patty Ewing; Donna Armentano; Gloria L Matthews
Journal:  Arthritis Res Ther       Date:  2015-01-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.